The company's purpose is to carry out and execute all activities in the field of human reproductive medicine, in particular homologous and heterologous insemination, in-vitro fertilization with embryo transfer, gamete transfer and social freezing, possibly in combination with hormone treatments, as well as the establishment, acquisition, sale, management and restructuring of outpatient medical institutions. The company may enter into all transactions and conclude contracts, as well as undertake everything that directly or indirectly promotes the company's purpose or falls within the company's business area. The company may establish branches and subsidiaries in Switzerland and abroad, participate in companies in Switzerland and abroad, take over representations, provide financing for its own or third-party accounts, acquire, hold, manage, encumber and sell real estate, as well as acquire, exploit, encumber and sell patents, licenses and other intellectual property. The company may take financing, restructuring and intercession measures in favor of group companies or third parties, including granting them loans or securities.